Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ruthenium-catalyzed oxidative cleavage of olefins to aldehydes.

The Journal of organic chemistry·2001
Same author

Pharmacokinetics of testosterone after percutaneous gel or buccal administration.

Fertility and sterility·2001
Same author

The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2001
Same author

Calpain activity in the rat brain after transient forebrain ischemia.

Experimental neurology·2001
Same author

Sharpening low-energy, standard-model tests via correlation coefficients in neutron beta decay.

Physical review letters·2001
Same author

Creation of chimeric mutant axolotls: a model to study early embryonic heart development in Mexican axolotls.

Anatomy and embryology·2001

Related Experiment Video

Updated: May 21, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Carbon Ion Radiotherapy Reirradiation for Recurrent Malignancy: A Systematic Assessment.

H Ruan1, C Zhang2, S Chen3

  • 1Department of Radiation Oncology, Jiangxi Cancer Hospital, Jiangxi Cancer Center, 330029, Nanchang, Jiangxi Province, China; Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi 371-8511, Gunma, Japan.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|April 17, 2025
PubMed
Summary

Carbon ion reirradiation shows promise for treating recurrent cancers, offering favorable outcomes and low toxicity across various sites. This advanced radiation therapy is a potentially safe and effective option for challenging locoregional malignancies.

Keywords:
Carbon ionClinical outcomesLocoregional recurrenceMalignancyReirradiationToxicities

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.1K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

Related Experiment Videos

Last Updated: May 21, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.1K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Reirradiation is a significant clinical challenge in managing recurrent malignancies.
  • Modern radiation therapy advances have improved outcomes, but reirradiation remains complex.
  • Carbon ion radiotherapy offers potential advantages in dose distribution and radiobiology.

Purpose of the Study:

  • To systematically review clinical outcomes of carbon ion reirradiation for locoregional recurrent malignancies.
  • To evaluate the efficacy and safety of carbon ion reirradiation across diverse cancer types.
  • To assess the impact of concurrent chemotherapy on toxicity.

Main Methods:

  • Systematic review of 27 original studies.
  • Inclusion of studies on central nervous system, lung, head and neck, pancreas, liver, rectum, and gynecological sites.
  • Analysis of clinical outcomes including survival rates and toxicity.

Main Results:

  • Carbon ion reirradiation demonstrated favorable clinical outcomes with low high-grade toxicities.
  • Specific survival rates reported for nasopharyngeal carcinoma, glioblastoma, lung, and pancreatic cancers.
  • Concurrent chemotherapy showed minimal additive high-grade toxicities.

Conclusions:

  • Carbon ion reirradiation is a potentially safe and effective modality for locoregional recurrent malignancies.
  • Further research is needed due to limited data.
  • Carbon ion therapy represents a promising advancement in radiation oncology for recurrent disease.